編號
C8-017
徵稿主題
Prognosis Survival and Treatment Related Complications
題目
不可切除胰腺癌一線Modified FOLFIRINOX與Nab-Paclitaxel Plus Gemcitabine的真實世界療效比較
作者群
謝其霖1,
湯文誠1,3,
張境夫2,3,
吳教恩3,
謝佳訓1,
沈雯琪1,
郭永嘉1,
陳仁熙1,4,
黃文冠1,
周文其1,
王智升5
服務單位
1 Department of Hematology and Oncology, Linkou Chang Gung Memorial Hospital
2 Department of Hematology and Oncology, Taoyuan Chang Gung Memorial Hospital
3 Department of Hematology and Oncology, New Taipei Municipal TuCheng Hospital (Chang Gung Medical Foundation)
4 Department of Hematology and Oncology, Taipei Chang Gung Memorial Hospital
5 Department of Hematology and Oncology, Keelung Chang Gung Memorial Hospital
